Abstract
It is believed that most malignancies become more common with increasing age due to the requirement for several mutations to accumulate and subsequently interact. The age specific incidence of acute promyelocytic leukemia (APL) was investigated using population-based data from 77 million subject years of observation, yielding 149 consecutive cases. The incidence appears approximately constant with respect to age, an observation not previously reported with any other malignancy. These findings are most easily explained by there being only one rate limiting genetic event required to initiate the disease, although other, non-rate limiting mutations may also be necessary for disease development. It is also argued that this mutation is probably restricted to cells committed to differentiation, which may explain why APL is curable by chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vogelstein B, Kinzler KW . The multistep nature of cancer Trends Genet 1993 9: 138–141
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . Creation of human tumour cells with defined genetic elements Nature 1999 400: 464–468
Hethcote HW, Knudson AG . Model for the incidence of embryonal cancers: application to retinoblastoma Proc Natl Acad Sci USA 1978 75: 2453–2457
Varmus H, Weinberg RA . Genes and the Biology of Cancer Scientific American Library; WH Freeman and Co: New York 1993
Stein WD . Analysis of cancer incidence data on the basis of multistage and clonal growth models Adv Cancer Res 1991 56: 161–213
Loeb LA . Mutator phenotype may be required for multistage carcinogenesis Cancer Res 1991 51: 3075–3079
Fenaux P, Chomienne C, Degos L, Grimwade D . Acute promyelocytic leukemia: biology and treatment Semin Oncol 1997 24: 92–102
Bennett B, Booth NA, Croll A, Dawson AA . The bleeding disorder in acute promyelocytic leukemia: fibrinolysis due to u-PA rather than defibrination Br J Haematol 1989 71: 511–517
de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus Nature 1990 347: 558–561
Fenaux P, Degos L . Differentiation therapy for acute promyelocytic leukemia New Engl J Med 1997 337: 1076–1077
Peto R, Parish SE, Gray RG . There is no such thing as ageing, and cancer is not related to it. In: Likhachev A, Anisimov V, Montesano R (eds) Age-related Factors in Carcinogenesis, International Agency for Research on Cancer Scientific Publications: Lyon, No 58 1986 pp 43–53
Akiyama M, Kyoizumi S, Hirai Y, Kusonoki Y, Iwamoto KS, Makamura N . Mutation frequency in human blood cells increases with age Mutat Res 1995 338: 141–149
de Haan G, Van Zant G . Dynamic changes in mouse hematopoietic stem cell numbers during aging Blood 1999 93: 3294–3301
Taylor P, Jackson G, Vickers M, Ross J, Gorst D, Clough V, Brown M, Poctor S . A population based study on the effect of age, WCC, cytogenetics and ATRA on outcome in acute promyelocytic leukemia Blood 1997 90: 234b
Ramsey MJ, Moore DH, Briner JF, Lee DA, Olsen LA, Senft JR, Tucker JD . The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting Mutat Res 1995 338: 95–106
Green MHL, O'Neill JP, Cole J . Suggestions concerning the relationship between mutant frequency and mutation rate at the hrpt locus in human peripheral T-lymphocytes Mutat Res 1995 334: 323–339
Westervelt P, Ley TJ . Seed versus soil: the importance of the target cell for transgenic models of human leukemias Blood 1999 93: 2143–2148
David G, Terris B, Marchio A, Lavau C, Dejean A . The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice Oncogene 1997 14: 1547–1554
Early E, Moores M, Kakizuka A, Nason-Burchenal K, Martin P, Evans R, Dmitrowsky X . Transgenic expression of PML-RARα impairs myelopoiesis Proc Natl Acad Sci USA 1996 93: 7900–7904
Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ . Altered myeloid development and acute leukemia in transgenic mice expression PML-RAR alpha under control of cathepsin G regulatory sequences Blood 1997 89: 376–387
He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP . Acute leukemia with promyelocytic features in PML/RAR alpha transgenic mice Proc Natl Acad Sci USA 1997 94: 5302–5307
Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH . A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation Blood 1997 89: 4282–4289
Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM . A PML/RARα transgene initiates murine acute promyelocytic leukemia Proc Natl Acad Sci USA 1997 94: 2551–2556
Melnick A, Licht JD . Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 1999 93: 3167–3215
Heinzel T, Lavinsky R, Mullen T, Soderstrom M, Laherty C, Torchia J, Yang W-M, Brard G, Ngo S, Davie J, Seto E, Eisenman R, Rose D, Glass C, Rosenfeld M . A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression Nature 1997 387: 43–48
Onodera M, Kunisada T, Nishikawa S, Sakiyama Y, Matsumoto S, Nishikawa S . Overexpression of retinoic acid alpha suppresses myeloid cell differentiation at the promyelocytic stage Oncogene 1995 11: 1291–1299
Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG . The acute promyelocytic leukemia-specific PML/RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells Cell 1993 74: 423–431
Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P . PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR EMBO J 1993 12: 3171–3182
Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A . Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways Proc Natl Acad Sci USA 1995 92: 7401–7405
Lamorte VJ, Dyck JA, Ochs RL, Evans RM . Localisation of nascent RNA and CREB binding protein with the PML-containing nuclear body Proc Natl Acad Sci USA 1998 95: 4991–4996
Vallian S, Gaken JA, Gingold EB, Kouzarides T, Chang KS, Farzaneh F . Modulation of Fos-mediated AP1 transcription by the promyelocytic leukemia protein Oncogene 1998 16: 2843–2853
Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG . Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes Blood 1995 85: 1169–1174
Mozziconacci M-J, Liberatore C, Brunel V, Grignani F, Arnoulet C, Ferrucci PF, Fernandez F, Sainty D, Pelicci PG, Birg F, Lafage-Pochitaloff M . In vitro response to all trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes Gene Chromosomes Cancer 1998 22: 241–250
Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillon C, Picard F, Macintyre EA, Varet B . Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate non-clonal progenitors in acute promyelocytic leukemia Blood 1995 85: 2154–2161
Knuutila S, Majander P, Ruutu T . 8;21 and 15;17 translocations: abnormalities in a single cell lineage in acute myeloid leukemia Acta Haematol 1994 92: 88–90
Haferlach T, Loffler H, Nickenig C, Ramm-Petersen L, Meeder M, Schoch R, Schlegelberger B, Schnittger S, Schoch C, Hiddemann W . Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May–Grunwald-Giemsa staining and fluorescence in situ hybridisation techniques for the detection of the translocation t(15;17)(q22;q12) Br J Haematol 1998 103: 93–99
Bonnet D, Dick JE . Human acute myeloid leukaemia is organised as a hierarchy that originates from a primitive hematopoietic cell Nature Med 1997 3: 730–737
Vickers M, Brown GC, Cologne JB, Kyoizumi S . Modelling haemopoietic stem cell division by analysis of mutant red cells Br J Haematol(in press)
Acknowledgements
We wish to thank the many hematologists who contributed patients to this survey, in particular, Drs JRY Ross, V Clough and D Gorst who maintain the Oxford, Merseyside and North-Western Registers.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vickers, M., Jackson, G. & Taylor, P. The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia 14, 722–726 (2000). https://doi.org/10.1038/sj.leu.2401722
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401722
Keywords
This article is cited by
-
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021
BMC Cancer (2023)
-
Demographic and treatment risk factors of cancer-specific mortality among children and adolescent leukemia patients: a population-based study
Environmental Science and Pollution Research (2022)
-
Differentiation therapy revisited
Nature Reviews Cancer (2018)
-
LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia
Leukemia (2016)
-
Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients
Annals of Hematology (2016)